Related Experiment Video
Updated: Mar 30, 2026

Knee Arthrocentesis in Adults
Published on: February 25, 2022
Native Joint Septic Arthritis: Epidemiology, Clinical Features, and Microbiological Causes in a New Zealand
Nicholas Kennedy1, Steven T Chambers1, Imogen Nolan1
1From the Department of Rheumatology, Immunology and Allergy, the Department of Infectious Diseases, and Decision Support, Christchurch Hospital; the Department of Pathology, and the Department of Medicine, University of Otago; Canterbury Health Laboratories, Christchurch, New Zealand.N. Kennedy, MB ChB, Clinical Immunology/Rheumatology registrar, Department of Rheumatology, Immunology and Allergy, Christchurch Hospital; S.T. Chambers, MB ChB, MD, MSc, FRACP, Professor of Infectious Diseases, Department of Pathology, and Department of Medicine, University of Otago, and Department of Infectious Diseases, Christchurch Hospital; I. Nolan, Medical student, Department of Medicine, University of Otago; K. Gallagher, infectious diseases nurse, Department of Infectious Diseases, Christchurch Hospital; A. Werno, MD, PhD, FRCPA, Medical Director, Microbiology, Canterbury Health Laboratories; M. Browne, Decision Support, Christchurch Hospital; L.K. Stamp, MB ChB, FRACP, PhD, Department of Rheumatology, Immunology and Allergy, Christchurch Hospital, and Department of Medicine, University of Otago.
Objective:
To determine the epidemiology, clinical features, and microbiology of adult native joint septic arthritis in Canterbury, New Zealand, over a 5-year period in individuals with and without an underlying rheumatic disorder.
Methods:
Patients with native joint septic arthritis were identified retrospectively and classified by Newman's criteria. The clinical characteristics were described and comparisons made between those with and without underlying rheumatic disease.
Results:
Two hundred forty-eight cases of native joint septic arthritis (mean age 60, range 16-97 yrs) were identified with an overall incidence rate of 12.0/100,000/year (95% CI 10.6-13.6). Yearly incidence increased with age to a maximum of 73.4/100,000 in those > 90 years of age. Septic arthritis was iatrogenic in 16.9% of cases while 27% had an underlying inflammatory arthritis including gout (14.9%), calcium pyrophosphate disease (8.5%), and rheumatoid arthritis (4%). Few patients were taking immunosuppressant therapy, with just 1 taking a biological agent. Staphylococcus aureus was the most commonly identified organism. Those with underlying inflammatory arthritis were significantly older (73.6 yrs vs 55.6 yrs; p < 0.001), more likely to be female (55.2% vs 26.0%; p < 0.001), and to have septic polyarthritis (16.4% vs 4.4%; p = 0.002). The 30-day mortality was 2%, increasing to 6% at 90 days.
Conclusion:
The incidence of septic arthritis in Canterbury, New Zealand, is higher than in previous studies. Crystal arthropathy commonly coexisted with infection although autoimmune arthritis and immunosuppression was less of a factor than anticipated.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Clinical Significance of Antibiotic Resistance
Endocarditis II: Clinical Features of Infective Endocarditis
Atypical Pneumonia
Endocarditis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management

